Literature DB >> 27458279

National Comprehensive Cancer Network Recommendations on Molecular Profiling of Advanced Bladder Cancer.

Sumanta Kumar Pal1, Neeraj Agarwal2, Stephen Anthony Boorjian2, Noah M Hahn2, Arlene O Siefker-Radtke2, Peter E Clark2, Elizabeth R Plimack2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27458279      PMCID： PMC5379635          DOI： 10.1200/JCO.2016.68.1429

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  16 in total

1.  Breast Cancer Version 2.2015.

Authors:  William J Gradishar; Benjamin O Anderson; Ron Balassanian; Sarah L Blair; Harold J Burstein; Amy Cyr; Anthony D Elias; William B Farrar; Andres Forero; Sharon Hermes Giordano; Matthew Goetz; Lori J Goldstein; Clifford A Hudis; Steven J Isakoff; P Kelly Marcom; Ingrid A Mayer; Beryl McCormick; Meena Moran; Sameer A Patel; Lori J Pierce; Elizabeth C Reed; Kilian E Salerno; Lee S Schwartzberg; Karen Lisa Smith; Mary Lou Smith; Hatem Soliman; George Somlo; Melinda Telli; John H Ward; Dorothy A Shead; Rashmi Kumar
Journal:  J Natl Compr Canc Netw       Date:  2015-04       Impact factor: 11.908

2.  Exceptional Response on Addition of Everolimus to Taxane in Urothelial Carcinoma Bearing an NF2 Mutation.

Authors:  Siraj M Ali; Vincent A Miller; Jeffrey S Ross; Sumanta K Pal
Journal:  Eur Urol       Date:  2015-01-24       Impact factor: 20.096

3.  Non-Small Cell Lung Cancer, Version 6.2015.

Authors:  David S Ettinger; Douglas E Wood; Wallace Akerley; Lyudmila A Bazhenova; Hossein Borghaei; David Ross Camidge; Richard T Cheney; Lucian R Chirieac; Thomas A D'Amico; Todd L Demmy; Thomas J Dilling; M Chris Dobelbower; Ramaswamy Govindan; Frederic W Grannis; Leora Horn; Thierry M Jahan; Ritsuko Komaki; Lee M Krug; Rudy P Lackner; Michael Lanuti; Rogerio Lilenbaum; Jules Lin; Billy W Loo; Renato Martins; Gregory A Otterson; Jyoti D Patel; Katherine M Pisters; Karen Reckamp; Gregory J Riely; Eric Rohren; Steven E Schild; Theresa A Shapiro; Scott J Swanson; Kurt Tauer; Stephen C Yang; Kristina Gregory; Miranda Hughes
Journal:  J Natl Compr Canc Netw       Date:  2015-05       Impact factor: 11.908

Review 4.  PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy.

Authors:  Sandip Pravin Patel; Razelle Kurzrock
Journal:  Mol Cancer Ther       Date:  2015-02-18       Impact factor: 6.261

5.  Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer.

Authors:  Naiyer A Rizvi; Matthew D Hellmann; Alexandra Snyder; Pia Kvistborg; Vladimir Makarov; Jonathan J Havel; William Lee; Jianda Yuan; Phillip Wong; Teresa S Ho; Martin L Miller; Natasha Rekhtman; Andre L Moreira; Fawzia Ibrahim; Cameron Bruggeman; Billel Gasmi; Roberta Zappasodi; Yuka Maeda; Chris Sander; Edward B Garon; Taha Merghoub; Jedd D Wolchok; Ton N Schumacher; Timothy A Chan
Journal:  Science       Date:  2015-03-12       Impact factor: 47.728

6.  Bladder cancer.

Authors:  Peter E Clark; Neeraj Agarwal; Matthew C Biagioli; Mario A Eisenberger; Richard E Greenberg; Harry W Herr; Brant A Inman; Deborah A Kuban; Timothy M Kuzel; Subodh M Lele; Jeff Michalski; Lance C Pagliaro; Sumanta K Pal; Anthony Patterson; Elizabeth R Plimack; Kamal S Pohar; Michael P Porter; Jerome P Richie; Wade J Sexton; William U Shipley; Eric J Small; Philippe E Spiess; Donald L Trump; Geoffrey Wile; Timothy G Wilson; Mary Dwyer; Maria Ho
Journal:  J Natl Compr Canc Netw       Date:  2013-04-01       Impact factor: 11.908

7.  Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial.

Authors:  Jonathan E Rosenberg; Jean Hoffman-Censits; Tom Powles; Michiel S van der Heijden; Arjun V Balar; Andrea Necchi; Nancy Dawson; Peter H O'Donnell; Ani Balmanoukian; Yohann Loriot; Sandy Srinivas; Margitta M Retz; Petros Grivas; Richard W Joseph; Matthew D Galsky; Mark T Fleming; Daniel P Petrylak; Jose Luis Perez-Gracia; Howard A Burris; Daniel Castellano; Christina Canil; Joaquim Bellmunt; Dean Bajorin; Dorothee Nickles; Richard Bourgon; Garrett M Frampton; Na Cui; Sanjeev Mariathasan; Oyewale Abidoye; Gregg D Fine; Robert Dreicer
Journal:  Lancet       Date:  2016-03-04       Impact factor: 79.321

8.  Prevalence and co-occurrence of actionable genomic alterations in high-grade bladder cancer.

Authors:  Gopa Iyer; Hikmat Al-Ahmadie; Nikolaus Schultz; Aphrothiti J Hanrahan; Irina Ostrovnaya; Arjun V Balar; Philip H Kim; Oscar Lin; Nils Weinhold; Chris Sander; Emily C Zabor; Manickam Janakiraman; Ilana R Garcia-Grossman; Adriana Heguy; Agnes Viale; Bernard H Bochner; Victor E Reuter; Dean F Bajorin; Matthew I Milowsky; Barry S Taylor; David B Solit
Journal:  J Clin Oncol       Date:  2013-07-29       Impact factor: 44.544

9.  A Prognostic Gene Expression Signature in the Molecular Classification of Chemotherapy-naïve Urothelial Cancer is Predictive of Clinical Outcomes from Neoadjuvant Chemotherapy: A Phase 2 Trial of Dose-dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin with Bevacizumab in Urothelial Cancer.

Authors:  David J McConkey; Woonyoung Choi; Yu Shen; I-Ling Lee; Sima Porten; Surena F Matin; Ashish M Kamat; Paul Corn; Randall E Millikan; Colin Dinney; Bogdan Czerniak; Arlene O Siefker-Radtke
Journal:  Eur Urol       Date:  2015-09-03       Impact factor: 20.096

10.  Comprehensive molecular characterization of urothelial bladder carcinoma.

Authors: 
Journal:  Nature       Date:  2014-01-29       Impact factor: 49.962
View more
  3 in total

Review 1.  Emerging biomarkers and targeted therapies in urothelial carcinoma.

Authors:  Prateek Mendiratta; Petros Grivas
Journal:  Ann Transl Med       Date:  2018-06

Review 2.  [Immunotherapy for locally advanced and metastasized bladder cancer].

Authors:  W Loidl; F Luger
Journal:  Urologe A       Date:  2018-11       Impact factor: 0.639

3.  Evaluation of a nitinol stone retrieval basket as an alternative to biopsy forceps for biopsy of suspected upper tract genitourinary malignancies.

Authors:  Daniel J McClelland; Raven D Spencer; Ian W McArdle; Adam M Luchey; John T Barnard; Ali J Hajiran; Chad B Crigger; Gautum Agarwal; Chad E Morley
Journal:  Urol Ann       Date:  2022-05-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.